Press release
Minimal Residual Disease Testing Market worth $4.14 billion by 2030, growing at a CAGR of 12.25% - Exclusive Report by 360iResearch
The "Minimal Residual Disease Testing Market by Technology (Flow Cyclometry, Next-Generation Sequencing, Polymerase Chain Reaction), Indication (Leukemia, Lymphoma, Myeloma), End-User - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.The Global Minimal Residual Disease Testing Market to grow from USD 1.64 billion in 2022 to USD 4.14 billion by 2030, at a CAGR of 12.25%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/minimal-residual-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=sample
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Minimal Residual Disease Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Minimal Residual Disease Testing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Minimal Residual Disease Testing Market, highlighting leading vendors and their innovative profiles. These include Adaptive Biotechnologies Corporation, Agilus Diagnostics Ltd., Amgen Inc., ARUP Laboratories, AstraZeneca PLC, Asuragen Inc. by Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, C2I Genomics Inc., Cergentis B.V., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Genetron Holdings Limited, GRAIL, LLC by Illumina, Inc., Guardant Health, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., Kite Pharma, Inc. by Gilead Sciences, Inc., Laboratory Corporation of America Holdings, Mdxhealth BV, MedGenome Inc, Mission Bio, Inc., Myriad Genetics, Inc., Natera Inc., NeoGenomics Laboratories, Inc., OPKO Health, Inc., Quest Diagnostics incorporated, Sysmex Corporation, and Veracyte, Inc..
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/minimal-residual-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Minimal Residual Disease Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Technology, market is studied across Flow Cyclometry, Next-Generation Sequencing, and Polymerase Chain Reaction. The Polymerase Chain Reaction is projected to witness significant market share during forecast period.
Based on Indication, market is studied across Leukemia, Lymphoma, and Myeloma. The Leukemia is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Research Institutes, Diagnostic Laboratories, and Hospitals. The Academic & Research Institutes is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Minimal Residual Disease Testing Market, by Technology
7. Minimal Residual Disease Testing Market, by Indication
8. Minimal Residual Disease Testing Market, by End-User
9. Americas Minimal Residual Disease Testing Market
10. Asia-Pacific Minimal Residual Disease Testing Market
11. Europe, Middle East & Africa Minimal Residual Disease Testing Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Minimal Residual Disease Testing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Minimal Residual Disease Testing Market?
3. What is the competitive strategic window for opportunities in the Minimal Residual Disease Testing Market?
4. What are the technology trends and regulatory frameworks in the Minimal Residual Disease Testing Market?
5. What is the market share of the leading vendors in the Minimal Residual Disease Testing Market?
6. What modes and strategic moves are considered suitable for entering the Minimal Residual Disease Testing Market?
Read More @ https://www.360iresearch.com/library/intelligence/minimal-residual-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Minimal Residual Disease Testing Market worth $4.14 billion by 2030, growing at a CAGR of 12.25% - Exclusive Report by 360iResearch here
News-ID: 3273200 • Views: …
More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…

The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…

The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…

The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Minimal
Medical Devices Manufacturer Focused Minimal Invasive Surgery | YUWONMEDITECH
YUWONMEDITECH, founded in 2003 and based in Korea, is a specialized medical device manufacturer with a strong focus on minimally invasive surgery (MIS) solutions. The company is dedicated to developing advanced medical technologies that reduce patient recovery times, minimize surgical impact, and improve overall patient outcomes. With nearly two decades of experience, Yuwonmeditech combines innovation and precision engineering to provide high-quality, reliable medical devices for healthcare professionals worldwide. Their expertise…
Minimal Invasive Surgery Devices Market Report 2024 - Minimal Invasive Surgery D …
"The Business Research Company recently released a comprehensive report on the Global Minimal Invasive Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The minimal invasive…
New, minimal, online poetry community
In the age of social media, large corporation dominance, and AI, comes a breath of fresh air. A minimal, traditional online community, built from scratch with poetry in mind. The community is called, Kiss Poetry.
The clean and calming ways of Kiss Poetry can be seen right away due to the minimal, yet modern design. On the Write page is a single box where you write. Titles are auto-detected, as well…
Minimal Frame Window System Market Trends, Challenges, and Opportunities 2023 To …
The Minimal Frame Window System market is expected to grow at a CAGR of 10.3% from 2023 to 2030.
The Minimal Frame Window System market pertains to the architectural and construction industry, offering window solutions characterized by sleek, slim, and minimalist frames. These systems are designed to provide unobstructed views and maximize natural light in buildings. Minimal frame window systems are highly sought after in modern architecture and interior design for…
Minimal Window System Market Size Estimation: 2022, Development Trends , Growth …
The "Minimal Window System Market" Report 2022 provides a comprehensive analysis of the current market size, observable trends, key regions, growth rate, and projections. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. The report provides a detailed assessment of the key market dynamics and a qualitative analysis of the structure of the Minimal Window…
EvolIft® - Lift Off for minimal friction
In order to achieve the European Union's climate protection targets, CO2 emissions at fleet level must be reduced to < 60g CO2/km by 2030. The contribution of the sealing industry is, to reduce power losses to a technically possible minimum. KACO has further developed a principle based on turbine technology to enable its application in the automotive sector as well as in other industrial areas. The dynamic seal with the…